These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 12711577)
1. Are you missing your "must-use" medications? Harv Heart Lett; 2003 Apr; 13(8):6-7. PubMed ID: 12711577 [No Abstract] [Full Text] [Related]
2. Acute and chronic management of atrial fibrillation in patients with late-stage CKD. Aronow WS Am J Kidney Dis; 2009 Apr; 53(4):701-10. PubMed ID: 19324248 [No Abstract] [Full Text] [Related]
3. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening? Ho SF; O'Mahony MS; Steward JA; Burr ML; Buchalter M Age Ageing; 2004 Sep; 33(5):488-92. PubMed ID: 15271642 [TBL] [Abstract][Full Text] [Related]
4. [Betablockers and the treatment of chronic heart failure]. Martínez Martínez JA Medicina (B Aires); 1999; 59(6):793-7. PubMed ID: 10752230 [No Abstract] [Full Text] [Related]
11. Conclusions on the management of heart failure. Swedberg K J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S34-6. PubMed ID: 15526241 [TBL] [Abstract][Full Text] [Related]
12. [New strategies in the treatment of atrial fibrillation]. Tamargo Menéndez J An R Acad Nac Med (Madr); 2007; 124(2):305-16; discussion 316-8. PubMed ID: 18069598 [TBL] [Abstract][Full Text] [Related]
13. [Beta-blockers in the treatment of systolic dysfunction after myocardial infarction. Closing the circle?]. Martínez Martínez JA Medicina (B Aires); 2001; 61(3):376-7. PubMed ID: 11474890 [No Abstract] [Full Text] [Related]
14. Atrial fibrillation and heart failure: natural history and pharmacological treatment. Savelieva I; John Camm A Europace; 2004 Sep; 5 Suppl 1():S5-19. PubMed ID: 15450275 [TBL] [Abstract][Full Text] [Related]
15. Quality indicators for the management of heart failure in vulnerable elders. Fonarow GC Ann Intern Med; 2001 Oct; 135(8 Pt 2):694-702. PubMed ID: 11601952 [No Abstract] [Full Text] [Related]
16. Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. Jessup M; Banner N; Brozena S; Campana C; Costard-Jäckle A; Dengler T; Hunt S; Metra M; Rahmel A; Renlund D; Ross H; Warner Stevenson L J Heart Lung Transplant; 2006 Sep; 25(9):1003-23. PubMed ID: 16962463 [No Abstract] [Full Text] [Related]
17. Invited commentary. Thomas SP Ann Thorac Surg; 2009 Sep; 88(3):807-8. PubMed ID: 19699902 [No Abstract] [Full Text] [Related]
18. When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study. Izhar U; Ad N; Rudis E; Milgalter E; Korach A; Viola N; Levi E; Asraff G; Merin G; Elami A J Thorac Cardiovasc Surg; 2005 Feb; 129(2):401-6. PubMed ID: 15678052 [TBL] [Abstract][Full Text] [Related]
19. Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation. Hammwöhner M; Goette A J Cardiovasc Pharmacol; 2008 Jul; 52(1):18-27. PubMed ID: 18594479 [TBL] [Abstract][Full Text] [Related]